Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.

Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA.

Am J Epidemiol. 2012 Jun 1;175(11):1120-8. doi: 10.1093/aje/kws197. Epub 2012 May 11.

PMID:
22582207
2.

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.

Am J Epidemiol. 2012 Jun 1;175(11):1100-9. doi: 10.1093/aje/kws195. Epub 2012 May 11.

PMID:
22582210
3.

The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.

Tokars JI, Lewis P, DeStefano F, Wise M, Viray M, Morgan O, Gargiullo P, Vellozzi C.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):546-52. doi: 10.1002/pds.3220. Epub 2012 Mar 8.

PMID:
22407672
4.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group..

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
5.
6.

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, Baxter R, Jacobsen SJ, Irving S, Daley MF, Yin R, Naleway A, Nordin JD, Li L, McCarthy N, Vellozzi C, Destefano F, Lieu TA; Vaccine Safety Datalink Project..

Am J Prev Med. 2011 Aug;41(2):121-8. doi: 10.1016/j.amepre.2011.04.004.

PMID:
21767718
7.

Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6.

8.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium..

Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.

PMID:
23770307
9.

Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?

Nelson KE.

Am J Epidemiol. 2012 Jun 1;175(11):1129-32. doi: 10.1093/aje/kws194. Epub 2012 May 11.

PMID:
22582208
10.

Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.

Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW.

Am J Epidemiol. 2012 Jun 1;175(11):1110-9. doi: 10.1093/aje/kws196. Epub 2012 May 11.

11.

Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.

Polakowski LL, Sandhu SK, Martin DB, Ball R, Macurdy TE, Franks RL, Gibbs JM, Kropp GF, Avagyan A, Kelman JA, Worrall CM, Sun G, Kliman RE, Burwen DR.

Am J Epidemiol. 2013 Sep 15;178(6):962-73. doi: 10.1093/aje/kwt051. Epub 2013 May 6.

PMID:
23652165
12.

Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.

Huang WT, Yang HW, Liao TL, Wu WJ, Yang SE, Chih YC, Chuang JH.

PLoS One. 2013;8(3):e58827. doi: 10.1371/journal.pone.0058827. Epub 2013 Mar 11.

13.

The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.

Nguyen M, Ball R, Midthun K, Lieu TA.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:291-7. doi: 10.1002/pds.2323.

PMID:
22262619
14.

Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.

Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L.

Med J Aust. 2012 Nov 19;197(10):574-8. Erratum in: Med J Aust. 2014 Apr 7;200(6):321. Macdonnell, Richard [corrected to Macdonell, Richard].

PMID:
23163689
15.

Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.

Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):548-53. doi: 10.1002/pds.3575. Epub 2014 Feb 4.

PMID:
24497128
16.

Evaluating the safety of influenza vaccine using a claims-based health system.

McCarthy NL, Gee J, Lin ND, Thyagarajan V, Pan Y, Su S, Turnbull B, Chan KA, Weintraub E.

Vaccine. 2013 Dec 5;31(50):5975-82. doi: 10.1016/j.vaccine.2013.10.031. Epub 2013 Oct 19.

PMID:
24148577
17.

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.

Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222. eCollection 2014.

18.

Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.

Choe YJ, Cho H, Bae GR, Lee JK.

Vaccine. 2011 Mar 3;29(11):2066-70. doi: 10.1016/j.vaccine.2011.01.007. Epub 2011 Jan 19.

PMID:
21255684
19.

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F.

Vaccine. 2010 Oct 21;28(45):7248-55. doi: 10.1016/j.vaccine.2010.09.021. Epub 2010 Sep 16.

PMID:
20850534
20.

Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.

Ropero-Álvarez AM, Whittembury A, Bravo-Alcántara P, Kurtis HJ, Danovaro-Holliday MC, Velandia-González M.

Vaccine. 2015 Jan 1;33(1):187-92. doi: 10.1016/j.vaccine.2014.10.070. Epub 2014 Nov 6.

Supplemental Content

Support Center